Acetylcholinesterase noncovalent inhibitors based on a polyamine backbone for potential use against Alzheimer's disease [2]

Journal of Medicinal Chemistry

Volumn 41, Issue 22, 1998, Pages 4186-4189

  Melchiorre, Carlo ^a   Andrisano, Vincenza ^a   Bolognesi, Maria L ^a   Budriesi, Roberta ^a   Cavalli, Andrea ^a   Cavrini, Vanni ^a   Rosini, Michela ^a   Tumiatti, Vincenzo ^a   Recanatini, Maurizio ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; CHOLINESTERASE; CHOLINESTERASE INHIBITOR; DIAMINE DERIVATIVE; EDROPHONIUM; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; PHYSOSTIGMINE; POLYAMINE DERIVATIVE; TACRINE;

ALZHEIMER DISEASE; CHOLINESTERASE INHIBITION; DRUG MECHANISM; DRUG SYNTHESIS; ENZYME ACTIVE SITE; ENZYME INHIBITOR INTERACTION; HUMAN; LETTER; MOLECULAR DYNAMICS;

ACETYLCHOLINESTERASE; ALZHEIMER DISEASE; BINDING SITES; BUTYRYLCHOLINESTERASE; CHOLINESTERASE INHIBITORS; ERYTHROCYTES; HUMANS; KINETICS; LIGANDS; MODELS, MOLECULAR; POLYAMINES; RECEPTOR, MUSCARINIC M2; RECEPTORS, MUSCARINIC; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0032561371     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9810452     Document Type: Letter

References (32)

1. (a) Wurtman, R. J. Alzheimer's disease. Sci. Am. 1985, 252, 48-56.
2. (b) Altman, H. J., Ed. Alzheimer's Disease - Problems, Prospects and Perspectives; Plenum Press: New York, 1987.
3. Roberson, M. R.; Harrell, L. E. Cholinergic activity and amyloid precursor protein metabolism. Brain Res. Rev. 1997, 25, 50-69.
4. Kasa, P.; Rakonezay, Z.; Gulya, K. The cholinergic system in Alzheimer's disease. Prog. Neurobiol. (Oxford) 1997, 52, 511-535.
5. (a) Gualtieri, F.; Dei, S.; Manetti, D.; Romanelli, M. N.; Scapecchi, S.; Teodori, E. The medicinal chemistry of Alzheimer's and Alzheimer's-like diseases with emphasis on the cholinergic hypothesis. Farmaco 1995, 50, 489-503.
6. (b) Brufani, M.; Filocamo, L.; Lappa, S.; Maggi, A. New acetylcholinesterase inhibitors. Drugs Future 1997, 22, 397-410.
7. 2 antagonists: novel structures and pharmacology. Life Sci. 1993, 52, 497-503.
8. Inestrosa, N. C.; Alvarez, A.; Pérez, C. A.; Moreno, R. D.; Vicente, M.; Linker, C.; Casanueva, O. I.; Soto, C.; Garrido, J. Acetylcholinesterase accelerates assembly of amyloid-β-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme. Neuron 1996, 16, 881-891.
9. Melchiorre, C.; Yong, M. S.; Benfey, B. G.; Belleau, B. Molecular properties of the adrenergic α-receptor. II. Optimum covalent inhibition by two different prototypes of polyamine disulfides. J. Med. Chem. 1978, 21, 1126-1132.
10. Benfey, B. G.; Yong, M. S.; Belleau, B.; Melchiorre, C. Cardiac muscarinic blocking and atropinic blocking effects of a tetramine disulfide with α-adrenoceptor blocking activity. Can. J. Physiol. Pharmacol. 1979, 57, 41-47.
11. Benfey, B. G.; Brasili, L.; Melchiorre, C.; Belleau, B. Potentiation and inhibition of nicotinic effects on striated muscle by the tetramine disulfide benextramine. Can. J. Physiol. Pharmacol. 1980, 58, 984-988.
12. Melchiorre, C.; Cassinelli, A.; Quaglia, W. Differential blockade of muscarinic receptor subtypes by polymethylene tetraamines. Novel class of selective antagonists of cardiac M-2 muscarinic receptors. J. Med. Chem. 1987, 30, 201-204.
13. 2 muscarinic blocking activity as revealed by symmetrical and unsymmetrical poly amines. Farmaco 1991, 46, 417-434.
14. (b) Unpublished results.
15. Melchiorre, C.; Quaglia, W.; Picchio, M. T.; Giardinà, D.; Brasili, L.; Angeli, P. Structure-activity relationships among methoctramine-related polymethylene tetraamines. Chain-length and substituent effects on M-2 muscarinic receptor blocking activity. J. Med. Chem. 1989, 32, 79-84.
16. 2O) C, H, N.
17. 50 values which represent the concentration required to inhibit enzyme activity by 50%.
18. 3).
19. 25 Three concentrations of each inhibitor and four substrate concentrations were used; acetylthiocholine concentration never exceeded 0.55 mM, to avoid substrate inhibition. Duplicate assays were conducted at each of the concentration combinations, and the mean of the enzyme velocity values was used for graphical analysis (individual velocity values were all within ±5% of the mean value).
20. 26 bis-tetrahydroaminacridine inhibitors of AChE. These compounds bind simultaneously at both the catalytic and the peripheral sites of AChE and are characterized by "a linear mixed type of enzyme inhibition".
21. 28 and retrieved from the Brookhaven Protein Data Bank; Phe330 was replaced by Tyr, which is present in the human AChE, with the same conformation.
22. Yamamoto, Y.; Ishihara, Y.; Kuntz, I. D. Docking analysis of a series of benzylamino acetylcholinesterase inhibitors with a phthalimide, benzoyl, orindanone moiety. J. Med. Chem. 1994, 37, 3141-3153.
23. Harel, M.; Schalk, I.; Ehret-Sabattier, L.; Bouet, F.; Goeldner, M.; Hirth, C.; Axelsen, P.; Silman, I.; Sussman, J. Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 9032-9035.
24. Van Rossum, J. M. Cumulative dose-response curves. II. Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters. Arch. Int. Pharmacodyn. 1963, 143, 299-330.
25. The backbone atoms of Trp84 and Trp279 from the model and from the structure of AChE cocrystallized with decamethonium (Brookhaven Protein Data Bank entry 1acl) were aligned, and the resulting position of decamethonium is shown in Figure 2.
26. Ellmann, G. L.; Courtney, D.; Andres, V., Jr.; Featherstone, R. M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 1961, 7, 88-95.
27. (a) Eltze, M.; Figala, V. Affinity and selectivity of diperiden enantiomers for muscarinic receptor subtypes. Eur. J. Pharmacol. 1988, 158, 11-19.
28. 2 receptors. Br. J. Pharmacol. 1995, 114, 1507-1517.
29. Krupka, R. M.; Laidler, K. J. Molecular mechanisms for hydrolytic enzyme action. III. A general mechanism for the inhibition of acetylcholinesterase. J. Am. Chem. Soc. 1961, 83, 1454-1459.
30. Pang, Y.-P.; Quiram, P.; Jelacic, T.; Hong, F.; Brimijoin, S. Highly potent, selective, and low cost bis-tetrahydroaminacrine inhibitors of acetylcholinesterase. J. Biol. Chem. 1996, 271, 23646-23649.
31. Mohamadi, F.; Richards, N. G. J.; Guida, W. C.; Liskamp, R. M. J.; Lipton, M. A.; Caulfield, C. E.; Chang, G.; Hendrickson, T. F.; Still, W. C. MacroModel - an integrated software system for modeling organic and bioorganic molecules using molecular mechanics. J. Comput. Chem. 1990, 11, 440-467.
32. Sussman, J. L.; Harel, M.; Frolow, F.; Oefner, C.; Goldman, A.; Toker, L.; Silman, I. Atomic structure of acetylcholinesterase from Torpedo Californica: A prototypic acetylcholine-binding protein. Science 1991, 253, 872-879.